AVITA Medical Reports Fourth Quarter Fiscal 2019 Financial Results and Company Update

Link to Full Article • Total revenue of A$17.0 million for fiscal year 2019 (FY19), an increase of 50% year-over-year • U.S. product sales of A$6.2 million for FY19 • U.S. product sales of A$2.9 million for fourth quarter, an increase of 32% compared to FY third quarter sales Valencia, Calif., USA, and Melbourne, Australia, […]

RECELL® System Feasibility Study Results for Treatment of Diabetic Foot Ulcers Presented at 11th Annual Congress of the Japanese Society of Limb Salvage & Podiatric Medicine

Link to Full Article Innovative regenerative technology using patients’ own skin cells significantly reduced size of wounds caused by diabetic foot ulcers in all patients Valencia, Calif., USA, and Melbourne, Australia, 01 July 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) a global regenerative medicine company, announced today favorable results from an open-label feasibility study […]

AVITA Medical Announces RECELL® System Preliminary Data Focused on Vitiligo and Facial Acne Scars at the 24th Annual World Congress of Dermatology

Link to Full Article Abstracts Showcase Research on Potential Use of RECELL® System in Regenerative Dermatology Valencia, Calif., USA, and Melbourne, Australia, June 12, 2019 —AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announces new preliminary RECELL® Autologous Cell […]

Health Economic Model Published in Advances in Therapy Demonstrates Reduced Cost and Decreased Hospital Stay with the RECELL® System

Link to Full Article Real world experience found that the RECELL System could save one US Burn Center up to USD $28MM annually Valencia, Calif., USA, and Melbourne, Australia, 16 May 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today that the health economic model of the U.S. burn care pathway, developed in collaboration […]

AVITA Medical Appoints Interim CFO

Link to Full Article Valencia, Calif., USA, and Melbourne, Australia, 15 May 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company,  announced today that Dale A. Sander is resigning as Chief Financial Officer (CFO) to spend more time with his family on the east coast, effective immediately. Tim Rooney, AVITA’s Chief […]

AVITA Medical Announces Presentation at ABA Meeting Highlighting Results of Study Using RECELL® System to Treat Third-Degree Burns in Pediatric Patients

Professor Fiona Wood, co-inventor of the RECELL System, described her experience treating more than 3,500 patients using RECELL and resulting benefits including reduced time to healing and decreased length of hospitalization The publication of the RECELL System pivotal trial in the treatment of second-degree burns was selected as a top journal publication for 2018 Link […]

AVITA Medical to Present at Cowen and Company Health Care Conference

Valencia, Calif., USA, and Melbourne, Australia, 13 March 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that management will present at the Cowen and Company 39th Annual Health Care Conference in Boston. The presentation is being made on 13 March 2019 from 11:20 a.m. to 11:50 a.m. EDT at […]

Avita Medical Announces Collaboration with COSMOTEC, an M3 Group Company, to Commercialize the RECELL® System in Japan

COSMOTEC has filed a JPMDA application for approval to market the RECELL System in Japan Valencia, Calif., USA, and Melbourne, Australia, 4 March 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Group company, to market and distribute the RECELL® Autologous Cell […]

AVITA Medical Announces Temporary Interruption of Sales of Products in EU

–Sales temporarily interrupted while closing administrative and procedural open items related to EU certificates and unrelated to product performance -No impact on U.S. market Valencia, Calif., USA, and Melbourne, Australia, 4 March 2019 — AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that sales of the RECELL® Device in the […]